<DOC>
	<DOC>NCT02004340</DOC>
	<brief_summary>The purpose of this study is to determine whether transcutaneous auricular vagus nerve stimulation as a complementary therapy is effective in the treatment of pediatric epilepsy.</brief_summary>
	<brief_title>Transcutaneous Auricular Vagus Nerve Stimulation for Pediatric Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Diagnosed as epilepsy; With age between 218 years old; The number and dose of the medication was kept constant no less than eight weeks before intervention; The patients or their guardians can count the frequency of the seizures and finish the study. The patient is receiving the VNS therapy; Accompanied with progressive central nervous system diseases; Have severe heart, liver ,kidney or blood diseases; Be pregnant or having the schedule of pregnancy in the study period.</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>pediatric epilepsy</keyword>
	<keyword>transcutaneous vagus nerve stimulation</keyword>
</DOC>